C07K 16/1275
Streptococcus
Official title: Streptococcus (G)
C07K16/1275 (Streptococcus) appears on 251 US grants and 296 published applications in this corpus.
Search patents in C07K- Granted patents
- 251
- Published applications
- 296
- Assignees
- 192
- Inventors
- 592
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 12 | 2 |
| 2002 | 12 | 10 |
| 2003 | 3 | 16 |
| 2004 | 5 | 15 |
| 2005 | 4 | 10 |
| 2006 | 12 | 15 |
| 2007 | 7 | 13 |
| 2008 | 3 | 13 |
| 2009 | 8 | 12 |
| 2010 | 3 | 20 |
| 2011 | 9 | 12 |
| 2012 | 12 | 3 |
| 2013 | 10 | 18 |
| 2014 | 10 | 13 |
| 2015 | 12 | 19 |
| 2016 | 9 | 17 |
| 2017 | 17 | 13 |
| 2018 | 9 | 10 |
| 2019 | 10 | 12 |
| 2020 | 11 | 7 |
| 2021 | 6 | 9 |
| 2022 | 4 | 7 |
| 2023 | 10 | 9 |
| 2024 | 4 | 13 |
| 2025 | 4 | 2 |
| 2026 | 4 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof30 Jun 2026US 12,668,645 B2ModeX Therapeutics, Inc.
- Vaccine composition against Streptococcus suis infection16 Jun 2026US 12,653,878 B2Ceva Sante Animale
- Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, streptococcus vaccines, and methods for making and using them5 May 2026US 12,616,743 B2The Regents of the University of California
- Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection28 Apr 2026US 12,612,450 B2Adma Biomanufacturing, LLC
- Compositions and methods for the treatment of immunodeficiency18 Nov 2025US 12,473,351 B2Adma Biomanufacturing, LLC
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof17 Sep 2026US 2026/0274995 A1ModeX Therapeutics, Inc.
- Methods of analyzing recombinant polyclonal proteins3 Sep 2026US 2026/0259221 A1GigaGen, Inc.
- Modified mrna for multicell transformation6 Aug 2026US 2026/0224703 A1Tuhura Biosciences, Inc.
- Anti-microbial antibody signatures related to lung tumors and uses thereof9 Jul 2026US 2026/0194524 A1Arizona Board of Regents on behalf of Arizona State University
Most cited
By later US patents
- Transgenic plants expressing assembled secretory antibodies319US 5,959,177 AThe Scripps Research Institute · 1999
- Transgenic plants expressing assembled secretory antibodies273US 6,417,429 B1The Scripps Research Institute · 2002
- Method of passive immunization of mammals using avian antibody105US 4,748,018 AStolle Research & Development Corporation · 1988
- Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants92US 5,585,098 AOvimmune, Inc. · 1996
- Multivalent antigen-binding proteins69US 6,670,453 B2Unilever Patent Holdings B.V. · 2003